Das fortgeschrittene Urothelkarzinom der Harnblase beim älteren Patienten. Ein Überblick über Inzidenz, Prognose und therapeutische Möglichkeiten
Standard
Das fortgeschrittene Urothelkarzinom der Harnblase beim älteren Patienten. Ein Überblick über Inzidenz, Prognose und therapeutische Möglichkeiten. / Rink, M; Chun, F K; Chromecki, T F; Fajkovic, H; Dahlem, R; Fisch, M; Shariat, S F.
In: UROLOGE, Vol. 51, No. 6, 01.06.2012, p. 820-828.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Das fortgeschrittene Urothelkarzinom der Harnblase beim älteren Patienten. Ein Überblick über Inzidenz, Prognose und therapeutische Möglichkeiten
AU - Rink, M
AU - Chun, F K
AU - Chromecki, T F
AU - Fajkovic, H
AU - Dahlem, R
AU - Fisch, M
AU - Shariat, S F
PY - 2012/6/1
Y1 - 2012/6/1
N2 - INTRODUCTION: Age is suggested to be the greatest single risk factor for developing urothelial carcinoma of the bladder (UCB). This review presents an overview of the incidence, prognosis, surgical and medical therapy of UCB in elderly patients (> 65 years).RESULTS: Elderly patients have an approximate 11-fold increase in the incidence and a 15-fold increase in UCB mortality when compared to younger individuals. However, adequate surgical or medical treatment is less often or delayed offered to elderly patients. In properly selected cases, similar surgical outcomes and complication rates are reported in elderly patients, regardless of the type of urinary diversion. Application of perioperative systemic chemotherapy is dependent on physiologic deterioration and comorbidities. An adequate, restrictive case selection and early proactive postoperative rehabilitation are important factors to achieve good results.CONCLUSIONS: In adequately selected elderly patients, radical cystectomy and urinary diversion as well as systemic chemotherapy are feasible, safe and efficacious treatment options for advanced UCB.
AB - INTRODUCTION: Age is suggested to be the greatest single risk factor for developing urothelial carcinoma of the bladder (UCB). This review presents an overview of the incidence, prognosis, surgical and medical therapy of UCB in elderly patients (> 65 years).RESULTS: Elderly patients have an approximate 11-fold increase in the incidence and a 15-fold increase in UCB mortality when compared to younger individuals. However, adequate surgical or medical treatment is less often or delayed offered to elderly patients. In properly selected cases, similar surgical outcomes and complication rates are reported in elderly patients, regardless of the type of urinary diversion. Application of perioperative systemic chemotherapy is dependent on physiologic deterioration and comorbidities. An adequate, restrictive case selection and early proactive postoperative rehabilitation are important factors to achieve good results.CONCLUSIONS: In adequately selected elderly patients, radical cystectomy and urinary diversion as well as systemic chemotherapy are feasible, safe and efficacious treatment options for advanced UCB.
KW - Humans
KW - Treatment Outcome
KW - Prognosis
KW - Risk Assessment
KW - Survival Analysis
KW - Survival Rate
KW - Combined Modality Therapy
KW - Prevalence
KW - Patient Selection
KW - Antineoplastic Agents/therapeutic use
KW - Cystectomy/mortality
KW - Urinary Bladder Neoplasms/diagnosis/mortality/therapy
KW - Urinary Diversion/mortality
KW - Humans
KW - Treatment Outcome
KW - Prognosis
KW - Risk Assessment
KW - Survival Analysis
KW - Survival Rate
KW - Combined Modality Therapy
KW - Prevalence
KW - Patient Selection
KW - Antineoplastic Agents/therapeutic use
KW - Cystectomy/mortality
KW - Urinary Bladder Neoplasms/diagnosis/mortality/therapy
KW - Urinary Diversion/mortality
U2 - 10.1007/s00120-011-2769-2
DO - 10.1007/s00120-011-2769-2
M3 - SCORING: Zeitschriftenaufsatz
C2 - 22282102
VL - 51
SP - 820
EP - 828
JO - UROLOGE
JF - UROLOGE
SN - 0340-2592
IS - 6
ER -
